Periodic Reporting for period 1 - MOBIUS (MØBIUS: Transforming medication management for improved patient safety)
Reporting period: 2018-05-01 to 2018-08-31
Pharmacies, hospitals and long-term healthcare facilities across the world face enormous challenges related to managing safety and cost of medicines. Thousands of patients die or are seriously harmed each year from errors in the medicines management process, which also are a huge financial burden on healthcare systems.
Our project MØBIUS responds to the vast need for improvement in overall efficiency, precision, security and cost savings at drug management practices within hospitals and pharmacies.
Our goal is to customise and improve MØBIUS for commercialisation in the European market, adding major new functionalities and packaging the solution as a fully commercial product.
In order to understand the feasibility of launching MØBIUS in the European market we conducted an in-depth analysis of the market, its dynamics, environment, target customers and competitors, as well as the barriers that we foresee and the ways to overcome them. We have also updated the Freedom To Operate Analysis to ensure the freedom to exploit MØBIUS.
The production and commercialization of MØBIUS represents for Thula a bright opportunity to improve our product to enable a better medication system and increase of patient safety in line with the European policies that foster health care digitalisation.